Clinical Trial Update: Subcutaneously Administered MD-18 for the Treatment of Obesity and Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update for MD-18, investigating subcutaneous administration for obesity and diabetes, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Obesity

Drugs mentioned

• MD-18

Snippet

Sponsor: Cohen Global, Ltd. | Conditions: Healthy Volunteer | Phase 1 | Status: RECRUITING